Diagnosis and treatment of hepatocellular carcinoma with pelvic metastasis expressing AFP: a case report
This report presents the case of a 68-year-old female patient with hepatocellular carcinoma (HCC) who experienced persistently elevated alpha-fetoprotein (AFP) levels following resection of the primary liver tumor. The patient had previously undergone transcatheter arterial chemoembolization (TACE)...
Saved in:
Main Authors: | Legang Huang, Zijie Wang, Jiankuan Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1489725/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinoma
by: San-Chi Chen, et al.
Published: (2025-02-01) -
AFP shields hepatocellular carcinoma from macrophage phagocytosis by regulating HuR-mediated CD47 translocation in cellular membrane
by: Yinglian Pan, et al.
Published: (2025-02-01) -
NSUN5 Facilitates Hepatocellular Carcinoma Progression by Increasing SMAD3 Expression
by: Hexu Han, et al.
Published: (2025-01-01) -
Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
by: Masaud Shah, et al.
Published: (2025-01-01) -
Preoperative serum glutathione reductase activity and alpha-fetoprotein level are associated with early postoperative recurrence of hepatocellular carcinoma
by: Shen Lihong, et al.
Published: (2025-02-01)